Skip to main content
. 2019 Jan 16;43(3):1281–1288. doi: 10.3892/ijmm.2019.4066

Table III.

Scoring functions of each complex obtained by docking simulation.

Compound pIC50 5CAV
5CAS
−PLP1 −PLP2 −PMF −PLP1 −PLP2 −PMF
Emodin 4.33 64.62 71.20 91.21 73.07 76.99 93.72
Physicona 3.46 44.51 43.67 96.99 43.12 41.73 62.42
3 3.93 65.20 59.92 111.74 83.79 76.72 81.25
4 3.96 79.81 86.22 88.59 87.77 89.76 88.21
5 4.48 62.67 55.15 122.56 79.83 71.08 126.61
6 4.45 72.30 61.25 99.36 61.80 53.20 127.27
7a 4.34 102.78 101.73 86.88 75.07 70.05 150.17
8 4.37 103.66 94.66 101.74 95.34 90.63 109.19
9 4.41 56.21 51.77 104.36 55.03 54.33 105.17
10 3.63 53.83 52.39 76.19 60.32 63.13 76.37
11 3.79 64.02 65.84 51.38 61.56 54.57 79.38
12a 4.06 53.95 54.22 57.21 57.18 57.87 80.13
13a 3.51 67.65 72.88 42.90 54.8 49.32 76.73
14 2.64 59.11 56.33 68.86 58.39 60.44 83.99
15 4.83 47.60 48.20 89.25 50.42 53.99 101.97
16a 4.39 49.73 53.42 103.26 62.46 69.88 102.27
17a 5.14 45.57 48.18 87.04 55.28 58.20 95.57
18 3.04 64.69 64.20 58.02 65.39 63.78 86.34
19 3.74 54.02 55.81 91.70 60.02 63.80 84.75
20a 4.83 49.31 49.87 83.80 61.24 62.95 90.19
21 4.42 47.57 49.08 89.96 59.00 60.92 87.61
22 3.91 55.02 57.83 94.92 56.47 56.86 84.56
23 3.77 50.46 54.35 99.94 60.46 67.85 97.32
24a 4.38 56.09 54.18 89.29 55.40 47.37 75.34
25 4.49 58.32 56.39 68.49 58.22 62.31 92.49
26 4.44 54.69 54.25 46.94 56.09 55.54 76.29
27 4.01 58.49 58.55 62.80 61.69 58.24 50.50
28a 3.81 53.69 53.67 81.66 62.51 64.48 79.19
29 4.95 55.19 55.90 82.85 62.27 63.53 85.81
30 4.23 55.05 55.05 62.42 56.17 56.77 79.84
31 4.25 55.41 55.12 56.78 60.56 57.02 44.52
32 4.40 51.96 52.18 83.14 59.91 61.83 77.87
33 4.40 47.67 46.35 69.79 53.19 54.67 79.28
34 3.16 48.39 50.31 95.00 55.33 58.62 82.15
35 4.65 58.96 56.96 110.18 65.63 66.48 101.84
36 4.17 65.34 62.50 118.53 74.46 72.09 108.60
37a 4.48 63.10 60.99 130.19 80.10 77.80 122.05
38 4.40 68.72 68.51 129.06 81.43 79.45 127.00
a

Test set. IC50, half maximal inhibitory concentration; pIC50, −log(IC50).